Ptc Therapeutics earnings were -$38.4M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest PTCT earnings report on Jun 30, 2026 announced Q2 2026 earnings of $83.5M, down 3,072.4% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PTCT reported annual earnings of $682.6M, with -287.9% growth.
What were Ptc Therapeutics's earnings last quarter?
On PTCT's earnings call on Jul 30, 2026, Ptc Therapeutics (NASDAQ: PTCT) reported Q2 2026 earnings per share (EPS) of $1.01, up 221.69% year over year. Total PTCT earnings for the quarter were $83.50 million. In the same quarter last year, Ptc Therapeutics's earnings per share (EPS) was -$0.83.
As of the last Ptc Therapeutics earnings report, Ptc Therapeutics is currently losing money. Ptc Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$38.38 million, a 106.1% decrease year over year.
What was PTCT's earnings growth in the past year?
As of Ptc Therapeutics's earnings date in Jul 30, 2026, Ptc Therapeutics's earnings has grown year over year. PTCT earnings in the past year totalled -$38.38 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.